SEC Form 4
BioCardia, Inc. (BCDA) insider trading
In the 12 months to Oct 26, 2026, 2 BCDA insiders reported open-market purchases of $169.7K across 23 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $169.7K
- 23 filings
Who traded BCDA, and when
- Purchase
BCDA daily close from Oct 27, 2025 to Oct 26, 2026, between $0.77 and $1.47, last $0.89. 0 sale and 23 purchase filings by 2 insiders, marked at their filing dates. Simon H. Stertzer, Director: bought $103.6K across 1 filing, first filed Jun 24, 2026, last Jun 24, 2026. Peter Altman, President and CEO: bought $66.1K across 22 filings, first filed Dec 17, 2025, last Oct 20, 2026.
Largest mark · tap a row for others
Simon H. Stertzer · Director
Purchase $103,584
109,200 shares at $0.95 avg
Filed Jun 24, 2026 · traded Jun 22
Close on filing date $1.06
Simon H. Stertzer · Director
Director
$103.6K boughtPeter Altman · President and CEO
President and CEO
$66.1K boughtOpen-market trades
23 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Simon H. Stertzer | Director | — | $103.6K | 1 | — | |
| Peter Altman | President and CEO | — | $66.1K | 22 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Peter Altman President and CEO | Purchase | 500 | $0.95 | $475 | 385,385 | |
traded | Peter Altman President and CEO | Purchase | 1,000 | $1.03 | $1.0K | 384,885 | |
traded | Peter Altman President and CEO | Purchase | 1,900 | $1.05 | $2.0K | 383,885 | |
traded | Peter Altman President and CEO | Purchase | 800 | $1.09 | $872 | 381,985 | |
traded | Peter Altman President and CEO | Purchase | 5,400 | $0.93 | $5.0K | 381,115 | |
traded | Peter Altman President and CEO | Purchase | 1,900 | $0.92 | $1.7K | 375,785 | |
traded | Peter Altman President and CEO | Purchase | 5,000 | $0.78 | $3.9K | 373,885 | |
traded | Peter Altman President and CEO | Purchase | 500 | $0.83 | $415 | 368,885 | |
traded | Peter Altman President and CEO | Purchase | 4,300 | $0.87 | $3.8K | 368,385 | |
traded | Peter Altman President and CEO | Purchase | 7,500 | $0.96 | $7.2K | 369,485 | |
traded | Peter Altman President and CEO | Purchase | 5,400 | $0.96 | $5.2K | 361,985 | |
traded | Simon H. Stertzer Director | Purchase | 109,200 | $0.95 | $103.6K | 166,338 | |
traded | Peter Altman President and CEO | Purchase | 2,300 | $0.89 | $2.0K | 300,566 | |
traded | Peter Altman President and CEO | Purchase | 5,000 | $0.85 | $4.3K | 298,266 | |
traded | Peter Altman President and CEO | Purchase | 1,700 | $0.92 | $1.6K | 293,266 | |
traded | Peter Altman President and CEO | Purchase | 5,700 | $0.92 | $5.2K | 291,566 | |
traded | Peter Altman President and CEO | Purchase | 5,100 | $1.02 | $5.2K | 285,866 | |
traded | Peter Altman President and CEO | Purchase | 5,000 | $1.11 | $5.6K | 280,766 | |
traded | Peter Altman President and CEO | Purchase | 1,000 | $1.23 | $1.2K | 275,766 | |
traded | Peter Altman President and CEO | Purchase | 900 | $1.23 | $1.1K | 274,766 | |
traded | Peter Altman President and CEO | Purchase | 5,000 | $1.13 | $5.6K | 273,866 | |
traded | Peter Altman President and CEO | Purchase | 900 | $1.33 | $1.2K | 268,866 | |
traded | Peter Altman President and CEO | Purchase | 1,100 | $1.31 | $1.4K | 267,966 |
GET /stocks/filings/vX/form-4?tickers=BCDA&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"BCDA"
],
"issuer_cik": "0000925741",
"owner_cik": "0001647542",
"accession_number": "0001437749-26-033030",
"form_type": "4",
"filing_date": "2026-10-20",
"period_of_report": "2026-10-15",
"issuer_name": "BioCardia, Inc.",
"issuer_trading_symbol": "BCDA",
"owner_name": "Altman Peter",
"is_director": true,
"is_officer": true,
"officer_title": "President and CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-10-15",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 200,
"transaction_price_per_share": 0.95,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 385085,
"transaction_value": 190,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "This transaction was executed in multiple trades ranging from $0.94 to $0.95 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price."
}
]
},
{
"tickers": [
"BCDA"
],
"issuer_cik": "0000925741",
"owner_cik": "0001647542",
"accession_number": "0001437749-26-033030",
"form_type": "4",
"filing_date": "2026-10-20",
"period_of_report": "2026-10-15",
"issuer_name": "BioCardia, Inc.",
"issuer_trading_symbol": "BCDA",
"owner_name": "Altman Peter",
"is_director": true,
"is_officer": true,
"officer_title": "President and CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-10-16",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 300,
"transaction_price_per_share": 0.95,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 385385,
"transaction_value": 285,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F2",
"description": "This transaction was executed in multiple trades ranging from $0.94 to $0.96 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 12 records
- Tax withholding6 records
- Grants and awards6 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has BioCardia, Inc.'s CEO sold stock?
No. Peter Altman (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is BCDA’s insider data?
These are BCDA Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track BCDA insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for BCDA every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.